Several local anaesthetics and tranquillizers have been shown to interact with the cellular membranes (Seeman et al., 1972; Feinstein et al., 1975; Papahadjopoulos et al., 1975) . Among these, the commonly used phenothiazine tranquillizer chlorpromazine potentiated the hyperthermic response of a mouse fibrosarcoma (George & Singh, 1982) . Since plasma membrane is also involved in the hyperthermic killing of cells (Har-Kedar & Bleehen, 1976) , we have investigated the combined effect of heat and three other phenothiazine drugs viz. promethazine (PMZ); prochlorperazine (PCP) and trimeprazine (TMZ) on a mouse fibrosarcoma. The present study assumes considerable importance in view of their reported antitumour, chemo-and radio-sensitizing activities (Kanzawa et al., 1970; George & Singh, 1984) .
All drugs were pharmaceutical grade (May & Baker Ltd., India) and were used without any further purification. Their structural formulae and therapeutic uses are described elsewhere (George & Singh, 1984) .
A serially transplantable fibrosarcoma (Waravdekar & Ranadive, 1957) measurements of the intratumour and rectal temperatures were as described previously (George & Singh, 1982) . Briefly, tumours were locally heated by immersing in a thermostatically controlled (±+0.1C) waterbath (Gallenkamp, U.K.) fitted with a stirrer. Within 5-10min the tumours attained a temperature 0.5+0.2°C less than that of the waterbath which was maintained throughout the duration of the heating. It is known that the temperature across a tumour may vary considerably, but the intratumour temperature referred to in our study is the central tumour temperature.
Tumour regrowth delay was used as the criterion for assessing the response to various treatments. After each treatment the diameter of tumours were measured in 3 perpendicular directions and a geometric mean was calculated. The effectiveness of the treatments was assessed from the average time taken by the tumour to reach a diameter of 11 mm after each treatment.
At 2mg kg-1 body wt. all the drugs reduced the body temperature by 2°C but did not influence the tumour growth. At 25 mg kg-1 they produced a further drop in body temperature and also caused a small but measurable growth delay. At a higher dose of 40 mg kg-1 however, they considerably reduced the body temperature to 30.6°C and also significantly inhibited tumour growth; their effectiveness being TMZ > PCP = PMZ (growth delays 2.3+0.5; 1.4+0.5 and 0.9+0.5 days respectively). Antitumour activity of such phenothiazines has been reported earlier (Kanzawa et al., 1970; Hilf et al., 1971; Polliak & Levij, 1972) but the drug doses used in all these studies to obtain any sigrficant effect were too large to permit their use as chemotherapeutic agents. In addition, during local hyperthermic treatment of tumours at 41-43°C when the body temperature rose to 37.5°C, drug doses >2mgkg-1 proved lethal. Drugs at this dose only were therefore used in combination with heat.
It can be seen from Figure 1 that heat alone at 41°C or in combination with any one of these drugs at 2mgkg-1 yielded only minimal growth delays. In contrast, administration of any one of these drugs before heating the tumours to 42 or 43°C caused substantial delays in tumour growth compared to the tumours heated without these drugs. Their relative effectiveness was found to be TMZ > PMZ = PCP. A detailed study on TMZ showed that it was ineffective at 0.1 mg kg-but equally affected the tumour growth at 0.5, 1 or 2mgkg-1 indicating a saturation in the effect at 0.5mg kg-' dose (growth delay at 43°C was 9.1+ 0.6 days). It is significant to note that the acceptable clinical dose of TMZ is of the order of 0.6-0.9mgkg-1 ('Vallergan', May & Baker Ltd., U.K., 1972) . Figure 1 also shows the variation of growth delays at 41, 42 and 43°C and it indicates that while, in tumours treated with heat alone, advantage may be achieved by increasing the temperature up to 43°C; in combination treatment with these drugs particularly TMZ and PMZ, the major benefit is realised at 420C itself and treating at 43°C would lead only to a marginal further advantage. Considering the fact that these and other membrane active drugs interact with cellular membranes and modify their microenvironment (Seeman, 1972; Feinstein et al., 1975; Papahadjopoulos et al., 1975; Singer, 1977) as well as their response to heating (Yatvin, 1977) , it is very likely that they would also shift the temperature profiles for hyperthermic killing as seen in the present study. Such information may prove useful in planning treatment of cancer with hyperthermia in combination with drugs or radiation. 
